Amit Garg
[email protected] Cell: (305) 775-2285
Jupiter, FL 33458
Professional Objective: To advance my career in the biopharmaceutical industry as a specialty sales manager and use my skills, and experience to achieve specified goals. Differentiating Behaviors: Proactive, Ethical, Consistent, Enthusiastic, Collaborative, Competitive, Dependable Business Functions: Institutional and Physician Sales, Channel Account Contracting and Pricing/Reimbursement, New Product Launch, Marketing Campaign Development, Data Management, Professional Training/Development Disease State experience: Injectable Biotech therapies (IV, subcutaneous), Oral Therapies (PO) Cardiology, Hematology, Oncology, Endocrinology, Neuroscience, Pulmonology, Respiratory, Immunology, Gastroenterology Novo Nordisk® Pharmaceuticals, Inc. Senior Biopharmaceuticals Sales Manager Central and south Florida (Tampa/Orlando/West Palm Beach/Ft Lauderdale/Miami/Naples)
1/03 -6/14
Promote usage of Coagulation Factor VIIa Recombinant (NovoSeven®), and somatropin (DNA origin) injection, (Norditropin®) as indicated by FDA label. Targets: Hematology/oncology specialty physicians with subset of Cardiology centers, Endocrinologists, specialty treatment centers, contracting/distribution and reimbursement channels
• • • • • • •
Q1 2014 Ranked #3 in Nation 120% of $6,132,000 2013 Ranked #1 in Nation, 150% of $12,373,000 2011, 2013 Achieved ratings of OUTSTANDING 2009, 2010, 2012 Achieved ratings of EXCEEDS 2008 Achieved 112% of NovoSeven® of $12,466,002 2007 Achieved 84% of NovoSeven® of $13,527,363 **patient representing $8.4 million passed away April 2006
• • • •
2006: 2005: 2004: 2003:
70% of NovoSeven® of $18,905,803 101% of NovoSeven® 126% of Norditropin® 115% of NovoSeven® 142% of Norditropin® 103% of NovoSeven® 111% of Norditropin®
Direct Sales responsibilities and accolades: • Educating hematologists/oncologists and teaching institutions / sharing clinical usage research of NovoSeven®. • Disseminating Medical information to Cardiologists regarding EB during heart surgeries/catheterizations. • Educating endocrinologists and teaching institutions/ sharing clinic usage research of Norditropin. • Chosen to be member of Sales and Marketing Council (marketing rotation) for 2 years • Regionally lead CLOT team (national group working with senior leadership and marketing to discuss outcome based selling) • Lead nation in percentage of call reach and frequency for 2 years, 2006, 2007 • Educating and assisting regional endocrinology societies in regards to Norditropin Contracting experience 2003-Present: • Met, presented, and negotiated purchasing contracts to Florida specific hospitals, specialty pharmacies, and home health care accounts. • Negotiated and presented reimbursement schedules consistent with Florida Medicare and Medicaid contracts to Florida based distribution channels • Coordinated with headquarters/marketing function to create pricing strategy for Novoseven and Norditropin • Responsibilities encompassed monitoring compliance with existing contracts within legal framework • Participated in Medicare/Medicaid meetings supporting National Hemophilia Foundation efforts around granting equal access for patients to coagulation factors (presented cost benefit analysis when treating hemophilia). Targeted accounts within Florida Territory include: • Humana, Vista, Tenent, Aetna, Blue Cross Blue Shield of Florida, Florida Blood services • Curascript, Cardinal Specialty, Biocare, BDI, Prodigy • Walgreens/OptionCare • Caremark, Accredo/HHS • HOSS, Matrix Health Systems, Factor Foundation of America • Baptist Health system, Tenet Health system, Naples Health system • Broward Hospital System(Chris Evert Cancer Center), Memorial Hospital System(Joe Dimaggio Cancer Center) • University of Miami (Jackson Medical, Sylvester Cancer Center), Miami Childrens Cancer Center
Amit Garg
Cell (305) 775-2285
Pfizer (formerly Genetics Institute, Wyeth) Hemophilia Specialty Manager Responsible for increase in utilization of Factor VIII Recombinant (Refacto) Responsible for increase in utilization of Factor IX Recombinant (Benefix) products in Florida
• • •
4/02 – 1/03
Promoting products to hospitals via pharmacy directors, coagulation lab directors, social workers, case managers Initiating and promoting programs with the National Hemophilia Foundation and Hemophilia Foundation of Greater Florida Partnering with home health care and hematologists to identify patients for upgrading to recombinant products • Achieved 147% of Benefix quota, Q4 2002 • Achieved 162% of Benefix quota, Q3 2002 • Achieved 130% of Benefix quota, Q2 2002
Eli Lilly and Company Training and Development Associate • Onboarded new representatives for antipsychotic market • Developed disease state training materials • Administered coaching/role play scenarios • Evaluated and tested representatives to qualify for field ready experience
4/01-4/02
Neuroscience Hospital Specialist 5/00 – 4/02 Call on institutions in South Florida area and focus on psychiatrists for antipsychotic and antidepressant market, specifically Veteran’s Administration Hospitals and Florida State Hospital. Activities include: Prozac team leader, Bipolar team leader Earned Three awards for Peer leadership and teamwork honor, January 2002, June 2001, May 2000
• • • •
Achieved 120% of Zyprexa quota, Q1 2002 Achieved 120% of Prozac quota and 134% of Zyprexa quota, Jan - Dec 2001 Achieved 112% of Prozac quota and 132% of Zyprexa quota, May- Dec 2000 Achieved 105% of 2000 annual total dollar quota ($3.242 achieved vs. $3.077 million)
AstraZeneca (formerly Astra Merck) 5/97 – 4/00 Pharmaceutical Specialist Manage physician base and hospitals in Hollywood, Pembroke Pines, S. Ft. Lauderdale (cardiologists, gastroenterologists, pulmonologists, allergists, immunologists, primary care). • Set up learning programs for Nova Southeastern College (residents) • Maintain expenditure rates for budget through hosting physician programs • Partner with P&G and PDI for full potential of market share increase • Use PCL to maintain target and routing criteria and reflect minimum 70% allocation of samples • Physician based learning programs, teleconferences, luncheons
• • •
Achieved 101% of Prilosec quota, 101% of Plendil quota Achieved 144% of RBOs, Achieved 105% of Prilosec quota, 101% Plendil, 121% Atacand,
Jan – Jun 1999 Jan – Dec 1998 Jan – Dec 1998
Abbott Laboratories, ROSS Products Division Retail Sales Representative Managed consumer products at retail level within south Florida territory. Products included:
• • • •
5/96 – 2/97
Ensure product line for adult nutritionals Similac, Isomil, Pediasure, Pedialyte, Toddlers Best for pediatric nutritionals Clear Eyes, CLR, Murine, Selsun Blue Practice category management at retail level EDUCATION
MBA, Management, Marketing and MIS conferred July 1995, University of South Florida, Tampa, Florida Bachelor of Arts in biology / psychology conferred May 1991 Rutgers College, Rutgers University, New Jersey References upon request
